Discordance Between Antibody and T Cell Responses in Recipients of Trivalent Inactivated Influenza Vaccine

Overview

Journal Vaccine

Specialty Allergy & Immunology

Date 2008 Mar 15

PMID 18339461

Citations 24

Authors

Mary Dawn T Co

Laura Orphin

John Cruz

Pamela Pazoles

Alan L Rothman

Francis A Ennis

Masanori Terajima

Affiliations

Soon will be listed here.

Abstract

Thirty adults were tested for humoral and cellular immune responses following immunization with the trivalent inactivated influenza vaccine. Modest but significant inverse correlations between the baseline and the fold changes in the number of IFNgamma-producing cells and the levels of neutralizing antibodies were observed. Specific increases in proliferative responses in the CD8 CD45RA+ population were noted after vaccination. Minimal correlations between neutralizing antibody titers and the number of IFNgamma-producing cells in terms of prevaccination levels or fold increases were observed. These results show specific increases in a CD8 T cell subset and discordant T and B responses induced by the trivalent inactivated influenza vaccine.

Citing Articles

Comprehensive immune profiling of dengue and chikungunya viral responses using a novel miniaturized automated whole blood cellular analysis system and mass cytometry in a pediatric cohort in Msambweni, Kenya.

Kowli S, Krystosik A, Hale M, Mutuku F, Amugongo J, Malumbo S Immunohorizons. 2025; 9(4).

PMID: 40048709 PMC: 11884800. DOI: 10.1093/immhor/vlaf006.

Cellular and Molecular Immunity to Influenza Viruses and Vaccines.

Kasten-Jolly J, Lawrence D Vaccines (Basel). 2024; 12(4).

PMID: 38675771 PMC: 11154265. DOI: 10.3390/vaccines12040389.

A Virus-Specific Immune Rheostat in the Immunome of Patients Recovering From Mild COVID-19.

Yeo J, Leong J, Tay S, Nadua K, Anderson D, Lim A Front Immunol. 2021; 12:674279.

PMID: 34113347 PMC: 8185226. DOI: 10.3389/fimmu.2021.674279.

Humoral immunogenicity of the seasonal influenza vaccine before and after CAR-T-cell therapy.

Walti C, Loes A, Shuey K, Krantz E, Boonyaratanakornkit J, Keane-Candib J medRxiv. 2021; .

PMID: 34013294 PMC: 8132269. DOI: 10.1101/2021.05.10.21256634.

Immune response to influenza vaccination in ESRD patients undergoing hemodialysis vs. hemodiafiltration.

Nongnuch A, Ngampongpan W, Srichatrapimuk S, Wongsa A, Thongpraphai S, Boonarkart C PLoS One. 2020; 15(2):e0227719.

PMID: 32012159 PMC: 6996846. DOI: 10.1371/journal.pone.0227719.

References

Gross P, Ennis F, Gaerlan P, DENSON L, DENNING C, SCHIFFMAN D . A controlled double-blind comparison of reactogenicity, immunogenicity, and protective efficacy of whole-virus and split-product influenza vaccines in children. J Infect Dis. 1977; 136(5):623-32. DOI: 10.1093/infdis/136.5.623. View

Thomas P, Keating R, Hulse-Post D, Doherty P . Cell-mediated protection in influenza infection. Emerg Infect Dis. 2006; 12(1):48-54. PMC: 3291410. DOI: 10.3201/eid1201.051237. View

Kuwano K, Braciale T, Ennis F . Cytotoxic T lymphocytes recognize a cross-reactive epitope on the transmembrane region of influenza H1 and H2 hemagglutinins. Viral Immunol. 1989; 2(3):163-73. DOI: 10.1089/vim.1989.2.163. View

Arlettaz L, Barbey C, Helg C, Chapuis B, Roux E, Roosnek E . CD45 isoform phenotypes of human T cells: CD4(+)CD45RA(-)RO(+) memory T cells re-acquire CD45RA without losing CD45RO. Eur J Immunol. 1999; 29(12):3987-94. DOI: 10.1002/(SICI)1521-4141(199912)29:12<3987::AID-IMMU3987>3.0.CO;2-4. View

McElhaney J, Upshaw C, Hooton J, Lechelt K, Meneilly G . Responses to influenza vaccination in different T-cell subsets: a comparison of healthy young and older adults. Vaccine. 1998; 16(18):1742-7. DOI: 10.1016/s0264-410x(98)00133-9. View

He X, Holmes T, Zhang C, Mahmood K, Kemble G, Lewis D . Cellular immune responses in children and adults receiving inactivated or live attenuated influenza vaccines. J Virol. 2006; 80(23):11756-66. PMC: 1642596. DOI: 10.1128/JVI.01460-06. View

Yamada Y, Meager A, Yamada A, Ennis F . Human interferon alpha and gamma production by lymphocytes during the generation of influenza virus-specific cytotoxic T lymphocytes. J Gen Virol. 1986; 67 ( Pt 11):2325-34. DOI: 10.1099/0022-1317-67-11-2325. View

Garcia-Canas V, Lorbetskie B, Bertrand D, Cyr T, Girard M . Selective and quantitative detection of influenza virus proteins in commercial vaccines using two-dimensional high-performance liquid chromatography and fluorescence detection. Anal Chem. 2007; 79(8):3164-72. DOI: 10.1021/ac0621120. View

Catalina M, Sullivan J, Brody R, Luzuriaga K . Phenotypic and functional heterogeneity of EBV epitope-specific CD8+ T cells. J Immunol. 2002; 168(8):4184-91. DOI: 10.4049/jimmunol.168.8.4184. View

10.

Hilleman M . Realities and enigmas of human viral influenza: pathogenesis, epidemiology and control. Vaccine. 2002; 20(25-26):3068-87. DOI: 10.1016/s0264-410x(02)00254-2. View

11.

Mackenzie C, Taylor P, Askonas B . Rapid recovery of lung histology correlates with clearance of influenza virus by specific CD8+ cytotoxic T cells. Immunology. 1989; 67(3):375-81. PMC: 1385356. View

12.

Rastogi S, Gross P, Bonelli J, Dran S, Levandowski R, Russo C . Time to peak serum antibody response to influenza vaccine. Clin Diagn Lab Immunol. 1995; 2(1):120-1. PMC: 170112. DOI: 10.1128/cdli.2.1.120-121.1995. View

13.

Bender B, Croghan T, Zhang L, Small Jr P . Transgenic mice lacking class I major histocompatibility complex-restricted T cells have delayed viral clearance and increased mortality after influenza virus challenge. J Exp Med. 1992; 175(4):1143-5. PMC: 2119177. DOI: 10.1084/jem.175.4.1143. View

14.

Rastogi D, Wang C, Mao X, Lendor C, Rothman P, Miller R . Antigen-specific immune responses to influenza vaccine in utero. J Clin Invest. 2007; 117(6):1637-46. PMC: 1878514. DOI: 10.1172/JCI29466. View

15.

Ennis F, Cruz J, Demkowicz Jr W, Rothman A, McClain D . Primary induction of human CD8+ cytotoxic T lymphocytes and interferon-gamma-producing T cells after smallpox vaccination. J Infect Dis. 2002; 185(11):1657-9. DOI: 10.1086/340517. View

16.

Harper S, Fukuda K, Uyeki T, Cox N, Bridges C . Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2004; 53(RR-6):1-40. View

17.

Gillespie G, Wills M, Appay V, OCallaghan C, Murphy M, Smith N . Functional heterogeneity and high frequencies of cytomegalovirus-specific CD8(+) T lymphocytes in healthy seropositive donors. J Virol. 2000; 74(17):8140-50. PMC: 112348. DOI: 10.1128/jvi.74.17.8140-8150.2000. View

18.

Kuwano K, Tamura M, Ennis F . Cross-reactive protection against influenza A virus infections by an NS1-specific CTL clone. Virology. 1990; 178(1):174-9. DOI: 10.1016/0042-6822(90)90391-4. View

19.

Boyum A . Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand J Clin Lab Invest Suppl. 1968; 97:77-89. View

20.

Currier J, Kuta E, Turk E, Earhart L, Loomis-Price L, Janetzki S . A panel of MHC class I restricted viral peptides for use as a quality control for vaccine trial ELISPOT assays. J Immunol Methods. 2002; 260(1-2):157-72. DOI: 10.1016/s0022-1759(01)00535-x. View